(Q81416970)
Statements
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies (English)
Noel M Kramer
Eric M Horwitz
Jonathan Cheng
John A Ridge
Steven J Feigenberg
Roger B Cohen
Nicos Nicolaou
Eric J Sherman
James S Babb
Jason A Damsker
Corey J Langer